Clinical Trials
2 trialsNCT07343401 2026-01-15
Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development
Alexandria University
Completed
NCT00621452 2014-08-06
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
Phase 1 Completed